Lack of Efficacy of Topical Calcineurin Inhibitor Pimecrolimus 1% on Pruritus of Severely Uremic Patients: A Randomized Double-Blind Study in 60 Patients
Restricted accessResearch articleFirst published online June, 2011
Lack of Efficacy of Topical Calcineurin Inhibitor Pimecrolimus 1% on Pruritus of Severely Uremic Patients: A Randomized Double-Blind Study in 60 Patients
MettangM, WeisshaarE. Pruritus: control of itch in patients undergoing dialysis. Skin Therapy Lett, 2010; 15:1-5.
2.
RazeghiE, EskandariD, GanjiM, et al.Gabapentin and uremic pruritus in hemodialysis patients. Ren Failure, 2009; 31:85-90, doi:10.1080/08860220802595476.
3.
KuypersDR, ClaesK, EvenepoelP, et al.A prospective proof of concept study of the efficacy of tacrolimus ointment on uremic pruritus in patients on chronic dialysis therapy. Nephrol Dial Transplant, 2004; 19:1895-901, doi:10.1093/ndt/gfh202.
4.
Pauli-MagnusC, KlumppS, AlscherDM, et al.Short-term efficacy of tacrolimus ointment in severe uremic pruritus. Perit Dial Int, 2000; 20:802-3.
5.
DuqueMI, YosipovitchG, FleischerABJr, et al.Lack of efficacy of tacrolimus ointment 0.1% for treatment of hemodialysis-related pruritus: a randomized, double-blind, vehicle-controlled study. J Am Acad Dermatol, 2005; 52:519-21, doi:10.1016/j.jaad.2004.08.050.
